ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,944Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 300

$536K Total Retail Price of All Prescriptions

Rank: 32 out of 300

387 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 387 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

2% of this provider’s 7,728 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 504 398 1 3
AMLODIPINE BESYLATE 447 384 2 4
LISINOPRIL 361 271 3 7
OMEPRAZOLE 329 285 4 2
ATORVASTATIN CALCIUM 321 255 5 13
METFORMIN HCL ER 254 186 6 100
FUROSEMIDE 222 181 7 5
TRAMADOL HCL 194 146 8 11
SERTRALINE HCL 179 138 9 40
LEVOTHYROXINE SODIUM 178 134 10 12
CRESTOR 172 133 11 49
HYDROCODONE-ACETAMINOPHEN 166 103 S3 12 1
ZOLPIDEM TARTRATE 160 143 13 16
METFORMIN HCL 160 117 13 24
CARVEDILOL 136 111 15 8
CLONIDINE HCL 134 114 16 39
ALLOPURINOL 131 113 17 64
LOVASTATIN 130 121 18 85
ALENDRONATE SODIUM 128 115 19 79
CLOPIDOGREL 125 104 20 18
ATENOLOL 121 114 21 27
METOPROLOL TARTRATE 115 94 22 26
POTASSIUM CHLORIDE 108 83 23 20
PRAVASTATIN SODIUM 108 102 23 17
METOPROLOL SUCCINATE 95 82 25 15
PLAVIX 95 80 25 32
SPIRIVA 93 66 27 53
CITALOPRAM HBR 90 78 28 46
HYDROCHLOROTHIAZIDE 90 69 28 21
LOSARTAN POTASSIUM 87 77 30 29
NIASPAN 85 79 31 158
PANTOPRAZOLE SODIUM 82 49 32 45
DIOVAN 79 69 33 84
NEXIUM 78 54 34 44
DONEPEZIL HCL 77 76 35 33
GLIPIZIDE ER 76 66 36 266
ESCITALOPRAM OXALATE 75 61 37 101
GABAPENTIN 73 56 38 6
ISOSORBIDE MONONITRATE ER 71 65 39 55
SYNTHROID 69 54 40 201
AMITRIPTYLINE HCL 66 51 R 41 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 49 42 47
ADVAIR DISKUS 63 33 43 75
FENOFIBRATE 59 54 44 73
GLIPIZIDE 57 49 45 156
SINGULAIR 57 43 45 115
LIPITOR 56 48 47 211
ZETIA 56 44 47 151
KLOR-CON M20 55 45 49 87
LOSARTAN-HYDROCHLOROTHIAZIDE 54 48 50 76
RAMIPRIL 52 35 51 57
QUINAPRIL HCL 50 50 52 296
DIGOXIN 50 35 52 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.